Technical Analysis for NARI - Inari Medical, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical NARI trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.17% | |
| Spinning Top | Other | 0.17% | |
| Stochastic Reached Overbought | Strength | 0.17% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
| Possible Pocket Pivot | 2 days ago |
| 60 Minute Opening Range Breakout | 2 days ago |
Get this analysis on your stocks daily!
- Earnings date: 11/30/2020
Inari Medical, Inc. Description
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Catheter Hematology FDA Quality Of Life Vein Thrombosis Angiology Blood Clots Deep Vein Thrombosis Embolectomy Pulmonary Embolism Thrombectomy Thrombus Venous Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 127.42 |
| 52 Week Low | 39.55 |
| Average Volume | 558,488 |
| 200-Day Moving Average | 79.31 |
| 50-Day Moving Average | 108.13 |
| 20-Day Moving Average | 108.48 |
| 10-Day Moving Average | 107.32 |
| Average True Range | 6.60 |
| ADX | 12.41 |
| +DI | 22.30 |
| -DI | 20.84 |
| Chandelier Exit (Long, 3 ATRs ) | 107.62 |
| Chandelier Exit (Short, 3 ATRs ) | 115.20 |
| Upper Bollinger Band | 117.34 |
| Lower Bollinger Band | 99.62 |
| Percent B (%b) | 0.79 |
| BandWidth | 16.34 |
| MACD Line | 1.11 |
| MACD Signal Line | 0.35 |
| MACD Histogram | 0.7543 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 118.25 | ||||
| Resistance 3 (R3) | 117.85 | 115.90 | 117.49 | ||
| Resistance 2 (R2) | 115.90 | 114.73 | 116.11 | 117.23 | |
| Resistance 1 (R1) | 114.77 | 114.00 | 115.34 | 115.18 | 116.97 |
| Pivot Point | 112.83 | 112.83 | 113.11 | 113.03 | 112.83 |
| Support 1 (S1) | 111.70 | 111.65 | 112.26 | 112.10 | 110.31 |
| Support 2 (S2) | 109.75 | 110.93 | 109.96 | 110.05 | |
| Support 3 (S3) | 108.62 | 109.75 | 109.80 | ||
| Support 4 (S4) | 109.03 |
